IP Library Granted Patent US 7,674,892
Granted Patent B2
US 7,674,892 · App. 10/521,103 · Granted Mar 9, 2010

Hsp70 from

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,674,892
App. No.
10/521,103
Granted
Mar 9, 2010
Kind
B2
Abstract

The hsp70 gene from an Arthrobacter species has been isolated and sequenced. The encoded protein is believed to be highly immunogenic, especially in fish, and also has utility as a non-specific adjuvant, and as an adjuvanting carrier for heterologous antigens.

Claims (7)

1. An isolated nucleic acid sequence comprising: (a) the nucleic acid sequence of SEQ ID NO:1, or a fully complementary sequence thereof; (b) a nucleotide sequence which encodes amino acid residues 162 to 365 of SEQ ID NO:2, or a fully complementary sequence thereof; (c) nucleotides 291-2153 of SEQ ID NO:1, or a fully complementary sequence thereof; or (d) a nucleotide sequence, or a fully complementary sequence thereof, which under stringent conditions hybridizes with the sequence of SEQ ID NO:1 or its complement, wherein the stringent condition comprises washing for 1 hour at 55° C. with 1×SSC and 0.1% SDS.

2. The isolated nucleic acid sequence of claim 1 fused in-frame to a heterologous coding sequence.

3. The isolated nucleic acid sequence according to claim 2 , wherein said heterologous coding sequence encodes an antigen from a source selected from the group consisting of bacteria, virus, fungus, protozoa, nematode, and tumor.

4. A DNA expression Vector comprising the nucleic acid sequence of claim 1 , wherein said nucleic acid sequence is operably linked to a transcriptional regulatory sequence.

5. An isolated host cell transformed with the DNA expression vector of claim 4 .

6. An isolated nucleic acid molecule, comprising a nucleic acid sequence encoding SEQ ID NO:2, or its fully complementary sequence thereof.

7. A composition comprising the DNA expression vector of claim 4 and a pharmaceutically acceptable carrier.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2015
From: NOVARTIS AG
To: NOVARTIS TIERGESUNDHEIT AG
Reel/Frame 034926/0273 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2009
From: NOVARTIS ANIMAL HEALTH US, INC.
To: NOVARTIS AG
Reel/Frame 023669/0559 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2007
From: GRIFFITHS, STEVEN GARETH; RITCHIE, RACHAEL JANE; SIMARD, NATHALIE C.
To: NOVARTIS ANIMAL HEALTH US, INC.
Reel/Frame 020067/0001 →